Hwei‐Ming Wang

674 total citations
27 papers, 436 citations indexed

About

Hwei‐Ming Wang is a scholar working on Oncology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Hwei‐Ming Wang has authored 27 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 10 papers in Surgery and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Hwei‐Ming Wang's work include Colorectal Cancer Surgical Treatments (11 papers), Genetic factors in colorectal cancer (8 papers) and Colorectal Cancer Treatments and Studies (8 papers). Hwei‐Ming Wang is often cited by papers focused on Colorectal Cancer Surgical Treatments (11 papers), Genetic factors in colorectal cancer (8 papers) and Colorectal Cancer Treatments and Studies (8 papers). Hwei‐Ming Wang collaborates with scholars based in Taiwan, United States and Switzerland. Hwei‐Ming Wang's co-authors include Jaw‐Yuan Wang, Shiu‐Ru Lin, Li-Chen Yen, Tao‐Wei Ke, Ming‐Yii Huang, William Tzu‐Liang Chen, Yung‐Sung Yeh, Yi‐Chia Huang, Abe Fingerhut and Chien-Yu Lu and has published in prestigious journals such as Clinical Cancer Research, European Journal of Cancer and World Journal of Gastroenterology.

In The Last Decade

Hwei‐Ming Wang

27 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hwei‐Ming Wang Taiwan 12 294 113 112 96 79 27 436
Keigo Murakami Japan 11 245 0.8× 74 0.7× 148 1.3× 127 1.3× 132 1.7× 45 549
Oktay Bozkurt Türkiye 13 248 0.8× 105 0.9× 59 0.5× 88 0.9× 113 1.4× 44 427
Marta Briarava Italy 8 294 1.0× 166 1.5× 111 1.0× 122 1.3× 93 1.2× 10 486
Yoshinori Doki Japan 12 209 0.7× 88 0.8× 117 1.0× 179 1.9× 151 1.9× 40 544
Liangyu Bie China 14 163 0.6× 219 1.9× 54 0.5× 283 2.9× 124 1.6× 29 567
Juanjuan Shi China 16 170 0.6× 139 1.2× 183 1.6× 241 2.5× 71 0.9× 32 725
Eriko Nakano Japan 12 270 0.9× 115 1.0× 207 1.8× 133 1.4× 105 1.3× 44 511
Young Sun Lee United States 10 133 0.5× 111 1.0× 95 0.8× 125 1.3× 370 4.7× 17 580
Masayuki Itakura Japan 13 246 0.8× 76 0.7× 118 1.1× 141 1.5× 121 1.5× 47 474
Feng-Che Kuan Taiwan 9 170 0.6× 68 0.6× 49 0.4× 113 1.2× 135 1.7× 11 438

Countries citing papers authored by Hwei‐Ming Wang

Since Specialization
Citations

This map shows the geographic impact of Hwei‐Ming Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hwei‐Ming Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hwei‐Ming Wang more than expected).

Fields of papers citing papers by Hwei‐Ming Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hwei‐Ming Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hwei‐Ming Wang. The network helps show where Hwei‐Ming Wang may publish in the future.

Co-authorship network of co-authors of Hwei‐Ming Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Hwei‐Ming Wang. A scholar is included among the top collaborators of Hwei‐Ming Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hwei‐Ming Wang. Hwei‐Ming Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Mingcheng, Wen‐Ling Liao, Tao‐Wei Ke, et al.. (2023). Acupuncture May Help to Prevent Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Sham-Controlled, Single-Blind Study. The Oncologist. 28(6). e436–e447. 7 indexed citations
2.
Hung, Shih‐Ya, Hung‐Chang Chen, Tao‐Wei Ke, et al.. (2021). Noninferiority clinical trial comparing the bowel cleansing efficacy of sodium phosphate tablets (Quiklean®) with a polyethylene glycol/bisacodyl kit. World Journal of Gastroenterology. 27(5). 428–441. 1 indexed citations
3.
Seow‐En, Isaac, Tao‐Wei Ke, Hongchang Chen, et al.. (2021). Laparoscopic total pelvic peritonectomy for colorectal cancer pelvic carcinomatosis: a retrospective case series and photographic/videographic step-by-step guide. Surgical Endoscopy. 36(3). 2178–2191. 3 indexed citations
4.
Tsai, Hsiang‐Lin, Ching‐Wen Huang, Jui‐Ho Wang, et al.. (2020). Determination of the UGT1A1 polymorphism as guidance for irinotecan dose escalation in metastatic colorectal cancer treated with first-line bevacizumab and FOLFIRI (PURE FIST). European Journal of Cancer. 138. 19–29. 27 indexed citations
6.
Wang, Hwei‐Ming, et al.. (2014). The Metabolic Syndrome Is Associated with an Increased Risk of Colorectal Polyps Independent of Plasma Homocysteine. Annals of Nutrition and Metabolism. 64(2). 106–112. 4 indexed citations
7.
Huang, Shih‐Chien, et al.. (2014). High serum folate might have a potential dual effect on risk of colorectal cancer. Clinical Nutrition. 34(5). 986–990. 15 indexed citations
8.
Wang, Hwei‐Ming, et al.. (2013). High homocysteine is associated with increased risk of colorectal cancer independently of oxidative stress and antioxidant capacities. Clinical Nutrition. 33(6). 1054–1060. 25 indexed citations
9.
Wang, Hwei‐Ming, et al.. (2011). Colorectal Cancer in Younger than 30 Years Old Group is not Associated with Poor Prognosis. 22(3). 93–98. 4 indexed citations
10.
Huang, Ming‐Yii, et al.. (2011). Overexpression of S100B , TM4SF4 , and OLFM4 Genes Is Correlated with Liver Metastasis in Taiwanese Colorectal Cancer Patients. DNA and Cell Biology. 31(1). 43–49. 41 indexed citations
11.
Huang, Ming‐Yii, et al.. (2011). EVI2B , ATP2A2 , S100B , TM4SF3 , and OLFM4 As Potential Prognostic Markers for Postoperative Taiwanese Colorectal Cancer Patients. DNA and Cell Biology. 31(4). 625–635. 22 indexed citations
12.
Yeh, Yung‐Sung, Hwei‐Ming Wang, Shiu‐Ru Lin, & Jaw‐Yuan Wang. (2011). Prognostic and Molecular Factors in Stage II Colorectal Cancer. 3(1). 2–8. 4 indexed citations
13.
Hsu, Tzu‐Chi, Hong‐Hwa Chen, Ming‐Chin Yang, et al.. (2011). Pharmacoeconomic Analysis of Capecitabine versus 5-Fluorouracil/Leucovorin as Adjuvant Therapy for Stage III Colon Cancer in Taiwan. Value in Health. 14(5). 647–651. 13 indexed citations
14.
Hsu, Ta-Wen, et al.. (2011). Pelvic exenteration for men with locally advanced rectal cancer: A morbidity analysis of complicated cases. Asian Journal of Surgery. 34(3). 115–120. 13 indexed citations
15.
Chen, Ming‐Cheng, et al.. (2011). Clinical experience in 89 consecutive cases of chronic radiation enterocolitis. Journal of the Chinese Medical Association. 74(2). 69–74. 3 indexed citations
16.
Wang, Hwei‐Ming, Shiu‐Ru Lin, Yih‐Huei Uen, & Jaw‐Yuan Wang. (2009). Molecular Detection of Circulating Tumor Cells in Colorectal Cancer Patients: From Laboratory Investigation to Clinical Implication. 1(1). 2–10. 5 indexed citations
17.
Chiu, Hua‐Hsien, Hwei‐Ming Wang, Li-Chen Yen, et al.. (2009). Enhancing Detection of Circulating Tumor Cells with Activating KRAS Oncogene in Patients with Colorectal Cancer by Weighted Chemiluminescent Membrane Array Method. Annals of Surgical Oncology. 17(2). 624–633. 39 indexed citations
18.
Lin, Kuan-Ming, et al.. (2007). Methylation of the PCDH21 (Protocadherin-21) Gene in Colorectal Cancer. 18(4). 93–98. 1 indexed citations
19.
Wang, Hwei‐Ming, et al.. (2007). The Operative Morbidity in Creation and Closure of Loop Ileostomy. 18(3). 73–80. 1 indexed citations
20.
Wang, Hwei‐Ming, et al.. (2003). Laparoscopic coloanal anastomosis for low rectal cancer.. PubMed. 6(4). 345–7. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026